Deep Origin is a biotechnology company that specializes in providing a platform designed to enhance life sciences research and development. The company develops accelerator technology software aimed at assisting biotechnology firms in speeding up early-stage drug research and development. Its platform features advanced yet user-friendly tools tailored for biomedical scientists and engineers, empowering them to advance scientific discoveries in the field. By facilitating innovation, Deep Origin supports the ongoing evolution of biomedicine and the exploration of new therapeutic solutions.
Biosim AI is a medical technology company focused on enhancing drug discovery through advanced artificial intelligence. By employing innovative methods, the company aims to significantly reduce the timeline associated with discovering new drugs. Its technology is designed to tackle diseases that are often deemed undruggable, thereby providing new opportunities for patients and the medical community. Through its efforts, Biosim AI seeks to enable and accelerate the drug discovery process with a level of precision that can transform healthcare outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.